Amanda C. Guidon

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum

Divyanshu Dubey, William S. David, Kerry L. Reynolds et al. · Annals of Neurology · 2020 · 229 citations

Timely Management, Disease Progression, Severe Neurological Toxicity +18

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz et al. · Journal for ImmunoTherapy of Cancer · 2021 · 197 citations · Full text

Immunodeficiencies, Immunology, Pathology +26

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

Douglas B. Johnson, Wyatt J. McDonnell, Paula I. González-Ericsson et al. · Nature Medicine · 2019 · 171 citations · Full text

Immunology, Antiviral Response, Pathology +8

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

Divyanshu Dubey, William S. David, Anthony A. Amato et al. · Neurology · 2019 · 162 citations

Immunology, Pathology, Inflammatory Neuropathy Cause +16